CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Jan. 31, 2020	Jan. 31, 2019
Operating activities
Net loss	$ (38,576)	$ (17,833)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	36,697	29,041
Amortization of share-based compensation	2,747	2,941
Prior period live inventory adjustment reversal	(2,800)	(9,600)
Deferred income taxes	5,169	(6,346)
Loss on asset disposals	(15)	0
Change in assets and liabilities:
Accounts receivable - trade	(7,289)	(1,661)
Accounts receivable - insurance	445	1,395
Income taxes	(15,888)	123
Inventories	(2,228)	(12,112)
Prepaid expenses and other assets	(10,181)	(10,072)
Right of use assets	(4,856)	0
Lease liabilities	(4,856)	0
Accounts payable	(17,225)	10,107
Accrued expenses and other liabilities	(16,747)	(7,322)
Total adjustments	(27,285)	(3,506)
Net cash used in operating activities	(65,861)	(21,339)
Investing activities
Capital expenditures	(71,245)	(83,388)
Net proceeds from sale of property and equipment	65	371
Net cash used in investing activities	(71,180)	(83,017)
Financing activities
Borrowings from revolving line of credit	110,000	60,000
Proceeds from issuance of restricted stock under stock compensation plans	268	198
Payments from issuance of common stock under stock compensation plans	(5,228)	(2,325)
Net cash provided by financing activities	105,040	57,873
Cash and cash equivalents at beginning of period	95,417
Cash and cash equivalents at end of period	63,416
Net change in cash and cash equivalents	(32,001)	(46,483)
Supplemental disclosure of non-cash investing and financing activities:
Capital expenditures included in accounts payable	7,026	11,162
Dividends payable	7,113	7,089
Cash and cash equivalents at beginning of period	95,417	121,193
Cash and cash equivalents at end of period	$ 63,416	$ 74,710